ResMed beats earnings forecasts on sleep device demand
The US-based Australian sleep apnoea device giant has exceeded expectations with strong second quarter numbers.
Rose Zhang breaks from full slate of Stanford classes to contend in LPGA opener
Rose Zhang knew this offseason couldn’t be like the last one. Last year, she took 20 units worth of classes at Stanford while ...
ResMed beats quarterly profit estimates on demand for sleep disorder devices
ResMed beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea, a common sleep disorder. ResMed makes continuous positive ...